STOCK TITAN
  1. Home
  2. LMNGF

LMNGF (LMNGF) Stock Price, News & Analysis

LMNGF OTC Pink

Company Description

LMNGF (OTC Pink: LMNGF) carries a market capitalization of $6.5M.

This page collects what Stock Titan holds for LMNGF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$6.5M
Market Cap
0.0
Shares outstanding

Latest News

View All
—

Clinical Study Collaborator HCL Sends First Surgically Excised Ovarian Cancer Tumors to BioVaxys for BVX-0918 Vaccine Process Development

clinical trial
—

Bio-Manufacturing Partner BioElpida Completes Next Phase of BVX-0918 GMP Production for EU Clinical Study

clinical trial
—

BioVaxys and The Ohio State University Progress Pan-Sarbecovirus Vaccine Research Program

—

International Patent Application Filed for Cervical Cancer Vaccine

—

BioVaxys Enters Critical Tumor Cell Supply Agreement with Deaconess Research Institute for BVX-0918 Bioproduction

—

BioVaxys Announces Bioproduction of BVX-1021 for its Pan-Sarbecovirus Program in Collaboration with The Ohio State University

LMNGF has 10 recent news articles. Key topics include clinical trial, private placement, conferences, covid-19. View all LMNGF news →

SEC Filings

View All

No SEC filings available for LMNGF.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

Frequently Asked Questions

What is the market cap of LMNGF (LMNGF)?

The market cap of LMNGF (LMNGF) is approximately 6.5M. Learn more about what market capitalization means .